One cruise ship. 9 related cases. 3 deaths. Is the only known human-to-human transmissible hantavirus crossing borders?
An outbreak linked to the MV Hondius Antarctic cruise ship has placed Andes virus (ANDV) back into the international public health spotlight.
As of May 2026, 11 confirmed cases and 3 reported deaths have been associated with the outbreak across multiple countries.
What makes Andes virus particularly concerning is that it remains the only hantavirus with documented human-to-human transmission.
For laboratories, public health agencies, and molecular surveillance teams, the incident highlights a growing challenge: how quickly emerging pathogens can move through globally connected environments.
| Category | Details |
|---|---|
| Virus Type | Orthohantavirus |
| Primary Disease | Hantavirus Pulmonary Syndrome (HPS) |
| Main Endemic Regions | Argentina, Chile, Patagonia |
| Human-to-Human Transmission | Confirmed (limited close contact) |
| Mortality Rate | Approximately 30%–50% |
| Incubation Period | 4–42 days |
| Early Symptoms | Fever, fatigue, headache, muscle pain |
| Severe Symptoms | Pulmonary edema, respiratory failure |
| Current Outbreak | MV Hondius Antarctic cruise outbreak |
| Public Health Concern | International passenger repatriation and delayed symptom recognition |
What Is Andes Virus?
Andes virus (ANDV) is a South American orthohantavirus capable of causing hantavirus pulmonary syndrome (HPS), a severe respiratory disease associated with significant mortality.
Unlike most hantaviruses, which are primarily transmitted through rodent exposure, Andes virus is currently recognized as the only hantavirus with confirmed human-to-human transmission.
Documented transmission events have typically involved:
- household exposure
- intimate contact
- caregiving settings
- healthcare-related exposure
Although transmission efficiency is considered far lower than influenza or COVID-19, the ability to form limited transmission chains significantly changes outbreak surveillance strategy.
What Is Andes Virus?
Andes virus (ANDV) is a South American orthohantavirus capable of causing hantavirus pulmonary syndrome (HPS), a severe respiratory disease associated with significant mortality.
Unlike most hantaviruses, which are primarily transmitted through rodent exposure, Andes virus is currently recognized as the only hantavirus with confirmed human-to-human transmission.
Documented transmission events have typically involved:
- household exposure
- intimate contact
- caregiving settings
- healthcare-related exposure
Although transmission efficiency is considered far lower than influenza or COVID-19, the ability to form limited transmission chains significantly changes outbreak surveillance strategy.
Why the MV Hondius Outbreak Matters
The concern surrounding the MV Hondius outbreak is not simply the number of infections.
It is the combination of:
- international passenger movement
- prolonged close-contact exposure
- delayed symptom recognition
- multinational repatriation after exposure
The MV Hondius departed from Ushuaia, Argentina, a major Antarctic cruise gateway, carrying passengers and crew from multiple countries.
Following the outbreak investigation, exposed travelers reportedly returned to:
- the United States
- France
- Spain
- the United Kingdom
- the Netherlands
- Australia
- Singapore
This transformed the incident from a localized infectious disease event into a broader international surveillance challenge.
Why Cruise Ships Create Unique Outbreak Risks
Cruise ships create conditions that can complicate infectious disease containment, including:
- enclosed environments
- shared dining and social spaces
- prolonged close-contact exposure
- multinational passenger movement
- limited onboard medical infrastructure
For pathogens with delayed symptom onset and international dispersal potential, surveillance challenges may continue long after passengers disembark.
This becomes particularly important for Andes virus, where incubation periods may extend up to 42 days.
Public health authorities have reportedly recommended extended monitoring periods for exposed individuals due to the virus’s prolonged incubation window and initially non-specific symptoms.
Andes Virus Symptoms Can Initially Appear “Ordinary”
One of the greatest diagnostic challenges associated with Andes virus is that early symptoms can resemble common viral infections.
Early Symptoms
- fever
- chills
- headache
- fatigue
- muscle pain
- nausea
- vomiting
Lower back pain and thigh pain are also commonly reported.
Because these symptoms overlap with influenza, respiratory viral infections, and other febrile illnesses, early recognition may be delayed.
Severe Symptoms
As disease progression continues, some patients may rapidly develop:
- dry cough
- shortness of breath
- pulmonary edema
- hypoxemia
- respiratory failure
Once pulmonary involvement develops, patients may require intensive supportive care.
Hantavirus pulmonary syndrome (HPS) associated with Andes virus can carry mortality rates estimated around 30%–50% depending on outbreak conditions and healthcare access.
Andes Virus Transmission Risk
Current evidence suggests Andes virus transmission between humans typically requires prolonged close contact rather than casual community exposure.
Risk settings may include:
- household exposure
- intimate contact
- caregiving environments
- healthcare-related contact
There is currently no evidence suggesting efficient airborne community spread comparable to COVID-19.
Why Early Detection Remains Difficult
One of the biggest public health concerns surrounding Andes virus is delayed differential diagnosis.
Early symptoms frequently overlap with:
- influenza
- seasonal respiratory infections
- COVID-19
- general febrile illness
This creates diagnostic complexity for:
- hospitals
- emergency clinicians
- public health agencies
- port health authorities
- research laboratories
Key epidemiological indicators that may warrant additional evaluation include:
- recent South America travel
- Antarctic cruise exposure
- unexplained fever
- respiratory symptoms
- close contact with suspected cases
By the time respiratory symptoms become severe, pulmonary involvement may already be progressing rapidly.
Molecular Surveillance Is Becoming Increasingly Important
The MV Hondius outbreak reflects a broader trend in emerging infectious disease monitoring:
pathogens once considered geographically limited are increasingly testing global surveillance systems.
From H5N1 and mpox to Marburg virus and hantaviruses, laboratories and public health organizations are placing growing emphasis on:
- rapid molecular detection
- surveillance readiness
- outbreak response capability
- flexible PCR infrastructure
- emerging pathogen monitoring
Early molecular identification remains critical for:
- exposure tracking
- epidemiological investigation
- case confirmation
- surveillance monitoring
Andes Virus RT-PCR Detection in Research and Surveillance Settings
As global attention surrounding Andes virus increases, many laboratories are evaluating surveillance preparedness and molecular testing workflows for hantavirus-related targets.
BP LabLine worked closely with Bioperfectus that just has developed an Andes Virus Real-Time PCR Kit (RUO) designed for research and surveillance applications.
The assay supports multiple sample types, including:
- whole blood
- serum
- throat swabs
- nasopharyngeal swabs
The kit is compatible with mainstream real-time PCR platforms commonly used in molecular laboratories.
Laboratories evaluating hantavirus surveillance readiness are also increasingly expanding broader molecular testing capability for hantavirus-related targets and emerging pathogen response workflows.
As pathogen boundaries continue to shift, the question is no longer only who can detect a virus.
It is who can recognize the risk earlier, respond faster, and help build surveillance capacity before transmission chains expand.
Frequently Asked Questions About Andes Virus
Can Andes virus spread from person to person?
Yes. Andes virus is currently recognized as the only hantavirus with documented human-to-human transmission, although transmission generally requires prolonged close contact.
What are the first symptoms of Andes virus?
Early symptoms commonly include fever, fatigue, headache, chills, and muscle pain. Initial symptoms may resemble influenza or other respiratory infections.
Why is the MV Hondius outbreak important?
The outbreak involved international travelers returning to multiple countries, increasing the complexity of public health monitoring and surveillance coordination.
Is Andes virus airborne like COVID-19?
Current evidence does not support efficient airborne community spread. Most documented transmission events have involved prolonged close-contact exposure.
How is Andes virus detected?
Molecular detection is commonly performed using RT-PCR assays targeting Andes virus RNA in blood or respiratory-related sample types.
What is the incubation period for Andes virus?
Reported incubation periods may range from approximately 4–42 days, which contributes to extended monitoring recommendations for exposed individuals.
Why are cruise ships considered higher-risk environments for outbreaks?
Cruise ships involve prolonged close-contact exposure, enclosed environments, shared facilities, and international passenger movement, all of which may complicate infectious disease containment.
Is there a vaccine or specific treatment for Andes virus?
There is currently no widely available vaccine or specific antiviral treatment approved for Andes virus infection. Supportive medical care remains essential.
Looking Ahead
The MV Hondius outbreak serves as another reminder that emerging infectious diseases are no longer isolated by geography alone.
As international travel, climate shifts, and global mobility continue to evolve, laboratories and surveillance systems are facing increasing pressure to recognize unusual pathogens earlier and respond more rapidly.
For molecular diagnostics teams, preparedness increasingly depends on:
- flexible surveillance infrastructure
- rapid detection capability
- outbreak monitoring readiness
- awareness of emerging epidemiological signals
In the evolving landscape of global infectious disease surveillance, the challenge is no longer simply detecting pathogens — but recognizing epidemiological risks early enough to respond before localized events become broader international monitoring challenges.
